share_log

康健國際醫療：截至2024年3月31日止之股份發行人的證券變動月報表

TOWN HEALTH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

香港交易所 ·  Apr 5 06:47
Summary by Moomoo AI
康健國際醫療（TOWN HEALTH）於2024年4月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的公司股份變動情況。報告顯示，公司的普通股股份數目和法定/註冊股本在3月份均無變動，普通股結存維持在30,000,000,000股，每股面值0.01港元，法定/註冊股本總額為300,000,000港元。優先股方面，公司持有的可轉換優先股數量亦無變動，結存為375,000,000股，法定/註冊股本為3,750,000港元。已發行股份方面，公司的普通股結存數目為6,773,522,452股，本月內無增減。此外，公司於2022年8月26日發行的B批次及C批次可換股債券，其認購價/轉換價為0.76港元，股東大會於2022年6月28日通過，本月底已發行總額無變動。公司秘書郭仲安確認，所有證券發行均已獲得董事會授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
康健國際醫療（TOWN HEALTH）於2024年4月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的公司股份變動情況。報告顯示，公司的普通股股份數目和法定/註冊股本在3月份均無變動，普通股結存維持在30,000,000,000股，每股面值0.01港元，法定/註冊股本總額為300,000,000港元。優先股方面，公司持有的可轉換優先股數量亦無變動，結存為375,000,000股，法定/註冊股本為3,750,000港元。已發行股份方面，公司的普通股結存數目為6,773,522,452股，本月內無增減。此外，公司於2022年8月26日發行的B批次及C批次可換股債券，其認購價/轉換價為0.76港元，股東大會於2022年6月28日通過，本月底已發行總額無變動。公司秘書郭仲安確認，所有證券發行均已獲得董事會授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
ON APRIL 5, 2024, TOWN HEALTH FILED AN UPDATED SECURITIES CHANGE MONTH REPORT WITH HONG KONG TRADING AND SETTLEMENT HOLDINGS LIMITED, REPORTING CHANGES IN COMPANY SHARES AS OF 31 MARCH 2024. The report shows that the number of ordinary shares and the regulated/registered share capital of the company remained unchanged in March. Ordinary shares remained at 30,000,000,000 shares with a face value of HK$0.01 per share and the total regulated/registered share capital was HK$300,000,000. In the case of preference shares, the number of convertible preferred shares held by the Company remained unchanged, amounting to 375,000,000 shares and the regulated/registered share capital of HK$3,750,000. In terms of issued shares, the number of ordinary shares outstanding of the company was 6,773,522,452 shares, which did not increase...Show More
ON APRIL 5, 2024, TOWN HEALTH FILED AN UPDATED SECURITIES CHANGE MONTH REPORT WITH HONG KONG TRADING AND SETTLEMENT HOLDINGS LIMITED, REPORTING CHANGES IN COMPANY SHARES AS OF 31 MARCH 2024. The report shows that the number of ordinary shares and the regulated/registered share capital of the company remained unchanged in March. Ordinary shares remained at 30,000,000,000 shares with a face value of HK$0.01 per share and the total regulated/registered share capital was HK$300,000,000. In the case of preference shares, the number of convertible preferred shares held by the Company remained unchanged, amounting to 375,000,000 shares and the regulated/registered share capital of HK$3,750,000. In terms of issued shares, the number of ordinary shares outstanding of the company was 6,773,522,452 shares, which did not increase during the month. In addition, the Company's B Batch and C Batch Convertible Notes issued on 26 August 2022 at a subscription/conversion price of HK$0.76 were approved by the General Meeting on 28 June 2022, with the total issued unchanged at the end of the month. Company Secretary Kwok Chung-An confirmed that all securities issuance has been authorised by the Board and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more